Neumora Therapeutics
Price & Volume
Stats
See more52W Range | $0.61-$11.57 |
Market Cap | $307.5M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.47 |
News
See moreYahoo Finance • 3 days ago
Biotech Stocks Shine After Hours: Novo Nordisk, IDEAYA, Healthcare Triangle Among Gainers
Yahoo Finance • 2 months ago
Neumora to initiate phase 1 study of oral obesity pill
Yahoo Finance • 2 months ago
October 2025's Top Penny Stocks To Watch
Yahoo Finance • 2 months ago
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
About
CFO | Mr. Michael Lee Milligan |
Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 95 |
